Paragonix Technologies (Braintree, Mass.) said today that its SherpaPak donor-heart transport system has been used successfully at Massachusetts General Hospital in Boston and other transplant centers around the U.S. and Europe.
The SheraPak combines cooling technology with safe, consistent methods for cold ischemic storage and transport of donor organs, according to the company, which is also developing and commercializing SherpaLung to transport donated lungs to recipients. Real-time reporting of preservation temperature allows for continuous monitoring of transport conditions of the donor heart. When the transport is completed, these data are downloaded to Bluetooth-enabled devices for record-keeping and sharing among the transplant team.